Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yovana Velazquez"'
Autor:
Kiriakos Koukoulias, Penelope G. Papayanni, Julia Jones, Manik Kuvalekar, Ayumi Watanabe, Yovana Velazquez, Sarah Gilmore, Anastasia Papadopoulou, Ann M. Leen, Spyridoula Vasileiou
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Reliable and sensitive characterization assays are important determinants of the successful clinical translation of immunotherapies. For the assessment of cytolytic potential, the chromium 51 (51Cr) release assay has long been considered the gold sta
Externí odkaz:
https://doaj.org/article/05d14051cbc94363a2c29ed3b40a0427
Autor:
Spyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, Aster G. Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, Kimberly Mooney, Natalia Lapteva, Bambi J. Grilley, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Todd N. Eagar, George Carrum, Kevin A. Grimes, Ann M. Leen, Premal Lulla
Publikováno v:
Haematologica, Vol 108, Iss 7 (2022)
Defects in T-cell immunity to SARS-CoV-2 have been linked to an increased risk of severe COVID-19 (even after vaccination), persistent viral shedding and the emergence of more virulent viral variants. To address this T-cell deficit, we sought to prep
Externí odkaz:
https://doaj.org/article/fe01c9fbf22e4de38523e9244e616c26
Autor:
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, Matthew French-Kim, Alejandro Torres Chavez, Sarah Gilmore, Cliona M. Rooney, Ann M. Leen
Publikováno v:
Haematologica, Vol 108, Iss 7 (2022)
Externí odkaz:
https://doaj.org/article/6cfcb57140cf4ef5bab7606016e44333
Autor:
Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Yovana Velazquez, Matthew French-Kim, Wingchi Leung, Suhasini Lulla, Catherine Robertson, Claudette Foreman, Tao Wang, Shaun Bulsara, Natalia Lapteva, Bambi Grilley, Matthew Ellis, Charles Kent Osborne, Angela Coscio, Julie Nangia, Helen E. Heslop, Cliona M. Rooney, Juan F. Vera, Premal Lulla, Mothaffar Rimawi, Ann M. Leen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Purpose: Adoptively transferred, ex vivo expanded multi-antigen-targeted T cells (multiTAA-T) represent a new, potentially effective, and nontoxic therapeutic approach for patients with breast cancer (BC). In this first-in-human trial, we investigate
Externí odkaz:
https://doaj.org/article/d2a1cea135ca47b2969fd4c6813e68ff
Autor:
Suhasini Lulla, Tsung-Yen Chang, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Yovana Velazquez, Jenny Stanton, Ann Leen
Publikováno v:
Journal of Hepatology. 77:S839
Autor:
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, Matthew French-Kim, Alejandro Torres Chavez, Sarah Gilmore, Cliona M. Rooney, Ann M. Leen
Publikováno v:
Haematologica.
Not available.
Autor:
Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, Helen Elisabeth Heslop, Kimberly Mooney, Kevin Grimes, George Carrum, LaQuisa Hill, Premal Lulla, Ann Marie Leen
Publikováno v:
Open Forum Infectious Diseases
Background The impact of COVID-19 has been profound with >170,000,000 confirmed cases worldwide and emerging variants being a cause of global concern. Defects in T-cell function and trafficking have been described among those with severe illness, and
Autor:
Kevin Grimes, Ayumi Watanabe, Helen E. Heslop, Premal Lulla, Yovana Velazquez, Aster Workineh, Manik Kuvalekar, Spyridoula Vasileiou, Ann M. Leen, Kimberly Mooney, Suhasini Lulla, LaQuisa Hill, George Carrum
Publikováno v:
Transplantation and Cellular Therapy
Autor:
George Carrum, Ann M. Leen, Kimberly Mooney, Kevin Grimes, Helen E. Heslop, Spyridoula Vasileiou, LaQuisa Hill, Aster Workineh, Ayumi Watanabe, Manik Kuvalekar, Premal Lulla, Yovana Velazquez, Suhasini Lulla
Publikováno v:
Blood
Background. On 11 March, 2020 the World Health Organization declared COVID-19, caused by SARS-CoV-2, a global pandemic with almost 17,000,000 confirmed cases worldwide by the end of July, of which 4,500,000 were in the US. Approximately 20% of patien